Aries Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Sell |
4,748
-148
| -3% | -$71K | 0.47% | 48 |
|
|
2026
Q1 | $2.41M | Sell |
4,896
-28
| -0.6% | -$15.2K | 0.53% | 45 |
|
|
2025
Q4 | $2.85M | Sell |
4,924
-75
| -2% | -$42.4K | 0.63% | 38 |
|
|
2025
Q3 | $2.42M | Sell |
4,999
-86
| -2% | -$40K | 0.57% | 40 |
|
|
2025
Q2 | $2.06M | Buy |
5,085
+110
| +2% | +$46K | 0.54% | 46 |
|
|
2025
Q1 | $2.48M | Buy |
4,975
+261
| +6% | +$141K | 0.67% | 40 |
|
|
2024
Q4 | $2.45M | Sell |
4,714
-115
| -2% | -$63.2K | 0.68% | 36 |
|
|
2024
Q3 | $2.99M | Sell |
4,829
-82
| -2% | -$48.5K | 0.82% | 31 |
|
|
2024
Q2 | $2.72M | Sell |
4,911
-30
| -0.6% | -$17.2K | 0.86% | 31 |
|
|
2024
Q1 | $2.87M | Hold |
4,941
| – | – | 0.93% | 27 |
|
|
2023
Q4 | $2.62M | Buy |
4,941
+1
| +0% | +$484 | 0.94% | 27 |
|
|
2023
Q3 | $2.41M | Buy |
4,940
+127
| +3% | +$67.7K | 0.94% | 28 |
|
|
2023
Q2 | $2.51M | Sell |
4,813
-118
| -2% | -$63.7K | 0.97% | 29 |
|
|
2023
Q1 | $2.84M | Sell |
4,931
-122
| -2% | -$68.8K | 1.17% | 22 |
|
|
2022
Q4 | $2.78M | Sell |
5,053
-12
| -0.2% | -$6.36K | 1.2% | 21 |
|
|
2022
Q3 | $2.6M | Buy |
5,065
+110
| +2% | +$61.6K | 1.15% | 22 |
|
|
2022
Q2 | $2.69M | Buy |
+4,955
| New | +$2.73M | 1.22% | 21 |
|
|
2022
Q1 | – | Sell |
-4,755
| Closed | -$3.17M | – | 204 |
|
|
2021
Q4 | $3.17M | Buy |
4,755
+78
| +2% | +$48.7K | 1.21% | 19 |
|
|
2021
Q3 | $2.67M | Buy |
4,677
+17
| +0.4% | +$9.33K | 1.13% | 24 |
|
|
2021
Q2 | $2.35M | Buy |
4,660
+40
| +0.9% | +$18.9K | 1.01% | 27 |
|
|
2021
Q1 | $2.21M | Buy |
4,620
+425
| +10% | +$203K | 0.99% | 28 |
|
|
2020
Q4 | $2.15M | Sell |
4,195
-64
| -2% | -$30K | 1.07% | 26 |
|
|
2020
Q3 | $1.88M | Buy |
4,259
+45
| +1% | +$18.6K | 1.07% | 26 |
|
|
2020
Q2 | $1.53M | Buy |
4,214
+163
| +4% | +$54.6K | 0.93% | 30 |
|
|
2020
Q1 | $1.17M | Buy |
4,051
+15
| +0.4% | +$4.73K | 0.89% | 34 |
|
|
2019
Q4 | $1.31M | Sell |
4,036
-60
| -1% | -$18.2K | 0.8% | 35 |
|
|
2019
Q3 | $1.16M | Sell |
4,096
-30
| -0.7% | -$8.59K | 0.77% | 37 |
|
|
2019
Q2 | $1.24M | Sell |
4,126
-30
| -0.7% | -$8.26K | 0.87% | 34 |
|
|
2019
Q1 | $1.14M | Sell |
4,156
-113
| -3% | -$28.1K | 0.85% | 37 |
|
|
2018
Q4 | $955K | Buy |
4,269
+45
| +1% | +$10.6K | 1.01% | 35 |
|
|
2018
Q3 | $1.03M | Hold |
4,224
| – | – | 0.93% | 33 |
|
|
2018
Q2 | $991K | Buy |
4,224
+90
| +2% | +$19.1K | 0.92% | 33 |
|
|
2018
Q1 | $890K | Buy |
4,134
+60
| +1% | +$12.6K | 0.86% | 38 |
|
|
2017
Q4 | $870K | Buy |
+4,074
| New | +$780K | 0.8% | 38 |
|
Other funds holding TMO
Aries Wealth Management's TMO Position: Q2 2026 in Review
Aries Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q2 2026, selling an estimated $71K and leaving 4,748 shares worth $2.38M. The position accounts for 0.47% of the portfolio, ranked #48.
Aries Wealth Management first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.17M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Aries Wealth Management held 4,748 shares of Thermo Fisher Scientific worth $2.38M as of Q2 2026.
- Aries Wealth Management sold 148 Thermo Fisher Scientific shares in Q2 2026, an estimated $71K.
- Thermo Fisher Scientific made up 0.47% of Aries Wealth Management's portfolio in Q2 2026, its #48 holding.
- Aries Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Aries Wealth Management's Thermo Fisher Scientific position peaked at $3.17M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.